Vensana Capital I GP, LLC - 09 Feb 2026 Form 4 Insider Report for SpyGlass Pharma, Inc. (SGP)

Reporting relationship: 10%+ Owner
Issuer ticker: SGP
Reported as of: 09 Feb 2026
Net transaction value: +$2,640,000
SEC form: 4
Accepted by SEC: 10 Feb 2026, 18:08:58 UTC
Prior SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC

Key filing fact

Vensana Capital I GP, LLC filed Form 4 for SpyGlass Pharma, Inc. (SGP) on 10 Feb 2026.

Key facts

This page summarizes Vensana Capital I GP, LLC's Form 4 filing for SpyGlass Pharma, Inc. (SGP).
9 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 10 Feb 2026, 18:08.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: +$2,640,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (4)

CIK 0001854073 Primary reporting owner

Vensana Capital I GP, LLC

Relationship: 10%+ Owner
Address: 3601 W. 76TH STREET, SUITE 20, EDINA
Signature: /s/ Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC
Signature date: 10 Feb 2026

CIK 0001757539

Vensana Capital I, L.P.

Relationship: 10%+ Owner
Address: 3601 W. 76TH STREET, SUITE 20, EDINA
Signature: /s/ Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC, the general partner of Vensana Capital I, L.P.
Signature date: 10 Feb 2026

CIK 0001523522

Nielsen Kirk G.

Relationship: 10%+ Owner
Address: 3601 W. 76TH STREET, SUITE 20, EDINA
Signature: /s/ Steven Schwen, as attorney-in-fact for Kirk Nielsen
Signature date: 10 Feb 2026

CIK 0001608710

Klein Peter Justin

Relationship: 10%+ Owner
Address: 3601 W. 76TH STREET, SUITE 20, EDINA
Signature: /s/ Steven Schwen, as attorney-in-fact for Peter Justin Klein
Signature date: 10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGP transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,690,230
Change %
Price
Shares after: 1,690,230
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F1, F2

SGP transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +548,067
Change %: +32%
Price
Shares after: 2,238,297
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F1, F2

SGP transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +548,067
Change %: +24%
Price
Shares after: 2,786,364
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F1, F2

SGP transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +359,255
Change %: +13%
Price
Shares after: 3,145,619
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F1, F2

SGP transaction

Common Stock

Purchase

Transaction value: $2,640,000
Shares: +165,000
Change %: +5.2%
Price: $16.00
Shares after: 3,310,619
Date: 09 Feb 2026
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGP transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -9,689,922
Change %: -100%
Price
Shares after: 0
Date: 09 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 1,690,230
Exercise price
Footnotes: F1, F2

SGP transaction Derivative

Series C-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -3,142,015
Change %: -100%
Price
Shares after: 0
Date: 09 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 548,067
Exercise price
Footnotes: F1, F2

SGP transaction Derivative

Series C-2 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -3,142,015
Change %: -100%
Price
Shares after: 0
Date: 09 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 548,067
Exercise price
Footnotes: F1, F2

SGP transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares: -2,059,573
Change %: -100%
Price
Shares after: 0
Date: 09 Feb 2026
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 359,255
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Vensana Capital I GP, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.

Footnote F2

These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). Vensana Capital I GP, LLC ("Vensana GP I") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the "GP I Managing Directors") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.